Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annals of the Rheumatic Diseases|July 15, 2005
Early T cell activation in the skin from patients with systemic sclerosisA Kalogerou, E Gelou, S Mountantonakis, et al.
Drugs Under Experimental and Clinical Research|February 1, 2006
Psychiatric factors in patients with sensitive skinE Zafiriou, N V Angelopoulos, E Zintzaras, et al.
Drugs Under Experimental and Clinical Research|February 1, 2006
Objective biophysical findings in patients with sensitive skinA V Roussaki-Schulze, E Zafiriou, D Nikoulis, et al.
Drugs Under Experimental and Clinical Research|January 24, 2006
Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasisA V Roussaki-Schulze, C Kouskoukis, E Klimi, et al.
International Journal of Clinical Pharmacology Research|January 13, 2006
Evaluation of cytokine serum levels in patients with plaque-type psoriasisA V Roussaki-Schulze, C Kouskoukis, E Petinaki, et al.
International Journal of Clinical Pharmacology Research|December 22, 2005
Identification of human papillomavirus DNA in melanoma biopsy specimens of Greek populationA V Roussaki-Schulze, C Kouskoukis, C Rammos, et al.
International Journal of Tissue Reactions|January 31, 2006
Increasing incidence of melanoma in central Greece: a retrospective epidemiological studyA V Roussaki-Schulze, C Rammos, E Rallis, et al.
The Pharmacogenomics Journal|June 4, 2014
A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek populationY Vasilopoulos, C Sarri, E Zafiriou, et al.
The Pharmacogenomics Journal|April 6, 2016
FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitorsE Mendrinou, A Patsatsi, E Zafiriou, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 22, 2022
A real-world, non-interventional, prospective study of the effectiveness and safety of apremilast in bio-naïve adults with moderate plaque psoriasis treated in the routine care in Greece - the 'APRAISAL' studyD Ioannides, N Antonakopoulos, V Chasapi, et al.
Pageof 2